| |
Forbes' management team combines extensive pharmaceutical, medical and biomedical knowledge with strategic business expertise. The Company has strengthened its management team of capable professionals in the areas of business development, finance and marketing to ensure the Company continues to achieve its goals.
 Charles A. Butt, B.Comm.
President and Chief Executive Officer
Mr. Butt has been a director of the Company since September 1999 and the President of the Company since April 2001, the CEO since March 2002; and the Senior Vice President, Commercial Operations of the Company July 2000 until March 2001. Mr. Butt has extensive international and North American experience in business management, marketing and sales in the healthcare industry. Prior to joining Forbes as Senior Vice President, Mr. Butt served as President of The Charson Group Inc., a healthcare consulting company, specializing in strategic planning and new product introductions, based in Toronto. Before moving into consulting, Mr. Butt headed up the Consumer Health Products Division for Lederle Laboratories (Canada), where he was responsible for the initiation and development of the Consumer Health Products Group. Mr. Butt has also worked in a variety of marketing and sales roles at Shulton Inc. in Europe, Africa and the Middle East as well as Colgate-Palmolive (UK).
 Laura Wessman, MBA
Senior Vice President, Operations
Appointed to Senior VP, Operations in 2006, Ms. Wessman was the Senior Vice President, Corporate Development of the Company since January 2004. Previously, Ms. Wessman was the Vice President, Business Development from October 2002 to January 2004, and Marketing Manager from December 2000 to October 2002. Ms. Wessman joined Forbes Medi-Tech in December 2000 and has been involved in both the nutraceutical and pharmaceutical divisions of the Company, including captaining the upscaling and commercial profiling of its AD & ADD technology. Ms. Wessman is responsible for chartering the Company's growth through in-house development as well as licensing and acquisitions. Prior to joining Forbes, Ms. Wessman held positions of increasing responsibility at North Aegean Petroleum and Cominco in the areas of process engineering and project management. Ms Wessman holds undergraduate degrees in Chemical Engineering and Biochemistry from the University of British Columbia and an MBA from Simon Fraser University, Vancouver, BC.
 David Goold, CA
Chief Financial Officer
Prior to joining Forbes, Mr. Goold held the position of Vice President and Chief Financial Officer for Vizon SciTec Inc., and its predecessor company BC Research Inc. for six years. With BC Research, in addition to being part of the senior management of the consulting research and development business, he was involved in the creation and financing of three technology based entities. Mr Goold's previous experience includes Vice President, Finance for a publicly listed manufacturing company, and international experience with a California based clothing manufacturer and distributor. Mr. Goold began his career at Price Waterhouse in 1980, working in their offices in Vancouver, BC and Johannesburg, South Africa. Mr. Goold received his Bachelor of Commerce degree from the University of British Columbia in 1980 and has been a member of the Institute of Chartered Accountants of B.C. since 1982.
 David Stewart, Ph.D.
Vice President, Regulatory Affairs (Nutraceutical) and Scientific Services
Dr. Stewart has successively been the Vice-President, Director, and Manager of Regulatory Affairs of the Company since May 1997. Dr. Stewart has over 34 years experience in pharmaceutical research within the pharmaceutical and biotechnology industries specializing in regulatory affairs, drug approvals, quality assurance and laboratory management. Previously, Dr. Stewart was in Regulatory Affairs at Toronto-based Biovail Corporation International, Organon International, and QLT Phototherapeutics Inc., in Vancouver, BC. Dr. Stewart has also held positions as Assistant Professor at the University of Toronto in the Department of Pharmacology, Faculty of Medicine. Dr. Stewart has published over 44 peer-reviewed scientific papers in the areas of cell membrane transport mechanisms, addiction research, drug metabolism and cholesterol metabolism. Dr. Stewart is the inventor on 7 United States Patents.
| | 
| |
